masses of the parotid glands, brain, or lungs), we conditionally recommend treatment with immunosuppressive therapy over surgical removal of the mass lesion with immunosuppressive therapy. Immunosuppressive therapy (with remission induction followed by remission maintenance) is almost always the initial treatment of choice for mass lesions Other considerations Recommendation: In patients with GPA/MPA, we conditionally recommend against dosing immunosuppressive therapy based on ANCA titer